Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87465dc71c0c26ef21d4f02e283b58b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
filingDate |
2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_134a3596b4ceb612c4aad79629b84260 |
publicationDate |
2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009105270-A1 |
titleOfInvention |
Kinase inhibition and anticancer therapy |
abstract |
This invention relates to novel uses for Compound E in the treatment of diseases, in particular cancer, associated with aberrant kinase expression. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013089538-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2426213-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011053938-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012028334-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011070150-A1 |
priorityDate |
2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |